MedTrace Pharma A/S: Financial statements 2023
CVR: 36497661
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
MedTrace Pharma A/S (CVR 36497661) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 2,645,338 and a net result of DKK -15,106,505 compared with DKK -37,035,484 the year before. That is an increase of 20.6% compared with the year before. The profit margin was -571.1%. Equity in the 2023 report amounted to DKK 285,237,322. The solvency ratio was 92.7%. The company had 36 employees in the financial year.
- Revenue
- DKK 2,645,338
- Gross Profit
- DKK 2,039,059
- Profit/Loss
- DKK -15,106,505
- Equity
- DKK 285,237,322
- Total Assets
- DKK 307,595,243
- Employees
- 36
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 2.6 mio. | 2 mio. | -15.1 mio. | 285.2 mio. | 36 |
| 2022 | 2.2 mio. | 1.9 mio. | -37 mio. | 161.2 mio. | 29 |
| 2021 | 1.5 mio. | 374 t. | -17.9 mio. | 93.7 mio. | - |
| 2020 | - | 3 mio. | 1.2 mio. | 34.6 mio. | 5 |
| 2019 | - | 1.1 mio. | -1 mio. | 5.7 mio. | 5 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of December 31, 2023, Claus Henrik Berner Møller has left the board of directors of MedTrace Pharma A/S.
As of December 31, 2023, Erik Anders Strömqvist has left the board of directors of MedTrace Pharma A/S.
As of December 31, 2023, Ann Kristin Brøgger Led has stepped down as director of MedTrace Pharma A/S.
As of December 4, 2023, Peter Juul Kristensen has joined the board of directors of MedTrace Pharma A/S.
As of September 18, 2023, is registered as an owner of MedTrace Pharma A/S with an ownership share of 10%.
As of September 11, 2023, Mads Spangaard Rasmussen has left the board of directors of MedTrace Pharma A/S.
MedTrace Pharma A/S has published its annual report for 2022. Revenue came to DKK 2,192,838, and the net result was DKK -37,035,484.
About MedTrace Pharma A/S
MedTrace Pharma A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2015. The company is registered under the industry Udlejning og leasing af andet materiel, udstyr og andre materielle aktiver til events. The company was previously named MedTrace A/S and Medtrace ApS. The management consists of Peter Juul Kristensen and Lykke Jul Rømer. The board consists of Erik Anders Strömqvist (chair), Cesare Orlandi, Charlotte Vindfeldt and Claus Henrik Berner Møller. The company's owners include Arbejdsmarkedets Tillægspension, MedTravest IV ApS and Swisscanto Private Equity I KmGK. The company has 32 employees (2026). In 2025, the company reported revenue of DKK 1,759,371 and a net result of DKK -35,131,112 compared with DKK -15,355,876 the year before. Equity in the 2025 report amounted to DKK 302,613,643.